Dave Heel

Dave Heel discloses dealings in Adaptogenics Health Corp. to SEDI. We count 2 filings; the first trade dates from 13 July 2026 and the latest from 28 September 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 6 October 2026, the filings show a transaction in Adaptogenics Health Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.